Primary hepatocellular carcinoma (HCC), the major type of liver cancer, is a leading cause of worldwide cancer-related death. End-stage liver cancer patients have limited treatment options due to the lack of druggable targets, ...
Apr 30, 2024
0
0
In a new study, Oregon Health & Science University researchers report that combined cannabis and nicotine use during pregnancy is associated with significantly higher risk of poor health outcomes for newborns compared with ...
May 7, 2024
0
39
As a malignant disease of the liver cells, hepatocellular carcinoma (HCC) is one of the main causes of cancer-related deaths. While the treatment options for this aggressive type of cancer remain limited, the incidence is ...
Apr 23, 2024
0
10
In 2016, The Jackson Laboratory (JAX) launched the Maine Cancer Genomics Initiative (MCGI) to bring the latest progress in cancer care to rural Maine patients. Now, after successfully expanding access to genome tumor testing ...
May 1, 2024
0
1
A single low dose of esketamine after childbirth reduces depressive episodes at 42 days postpartum among mothers with prenatal depression, according to a study published online April 10 in The BMJ.
Apr 20, 2024
0
0
Final 12-month data from the EXACT trial demonstrates safety and efficacy results for a vascular endothelial growth factor (VEGF) gene therapy treatment for patients who have advanced coronary artery disease (CAD). The late-breaking ...
May 2, 2024
0
0
New research led by Western Sydney University has shown that treatment of gestational diabetes from early pregnancy can not only reduce birth complications among babies and mothers, but can also reduce health costs by up ...
Apr 30, 2024
0
0
Scientists have found a potential treatment strategy for an aggressive type of leukemia by targeting enzymes used by cells to sense and adapt to oxygen levels.
Apr 18, 2024
0
37
A new study from Brigham and Women's Hospital suggests that positron emission tomography (PET) brain scans could reveal hidden inflammation in patients with multiple sclerosis (MS) who are being treated with highly-effective ...
Apr 23, 2024
0
2
Using spatial analysis of tissue samples, Cedars-Sinai investigators have identified patterns that could predict whether patients with the most common type of ovarian cancer will experience early relapse after treatment. ...
Apr 18, 2024
0
18
